| Entry |
|
|---|
| Name |
Apolizumab (USAN/INN) |
|---|
| Efficacy |
Antineoplastic, Anti-HLA-DR antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Target |
|
|---|
| Pathway |
| hsa04612 | Antigen processing and presentation |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: Ig superfamiy
MHC
HLA-DRB
D02967 Apolizumab (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
